NCT03355664View on ClinicalTrials.gov

Study to Compare the Triple ACT AL+AQ With the ACT AL in Cambodia and Vietnam

PHASE3CompletedINTERVENTIONAL
Enrollment

310

Participants

Timeline

Start Date

March 19, 2018

Primary Completion Date

March 4, 2020

Study Completion Date

March 4, 2020

Conditions
Malaria, Falciparum
Interventions
DRUG

ACT

Artemether-lumefantrine (20/120 mg) as a fixed dose combination twice daily for 3 days according to weight plus low dose primaquine at hour 24

DRUG

TACT

Artemether-lumefantrine (20/120 mg) as a fixed dose combination twice daily for 3 days according to weight plus Amodiaquine (150mg) twice daily for 3 days according to weight plus low dose primaquine at hour 24

Trial Locations (4)

1803

Siem Pang Health Center, Siem Pang

2401

Pailin Referral Hospital, Pailin

Unknown

Hospital for Tropical Diseases of Khanh Hoa,, Vạn Giã

Phuoc Long Hospital, Phước Long

All Listed Sponsors
lead

University of Oxford

OTHER

NCT03355664 - Study to Compare the Triple ACT AL+AQ With the ACT AL in Cambodia and Vietnam | Biotech Hunter | Biotech Hunter